TY  - JOUR

T1  - Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover - The Case of Pazopanib in Advanced Renal Cell Carcinoma

JO  - Oncology

UR  - http://eprints.whiterose.ac.uk/111326/

PY  - 2016/03/16

AU  - Diaz J

AU  - Sternberg CN

AU  - Mehmud F

AU  - Delea TE

AU  - Latimer N

AU  - Pandite L

AU  - Motzer RJ

ED  - 

DO  - DOI: 10.1159/000443647

VL  - 90

IS  - 3

SP  - 119

EP  - 126

Y2  - 2024/12/22

ER  -